×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Circulating Tumor Dna Market

ID: MRFR/HS/36915-HCR
100 Pages
Rahul Gotadki
October 2025

Rapport d’étude de marché sur l’ADN tumoral circulant (ADNct) par application (détection précoce du cancer, surveillance thérapeutique, surveillance des maladies, surveillance des récidives), par technologie (séquençage de nouvelle génération, techniques basées sur la PCR, PCR numérique, techniques basées sur des puces à ADN), par utilisation finale (hôpitaux, laboratoires cliniques, instituts de recherche, centres de diagnostic), par type de produit (réactifs, kits, instruments) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie... lire la suite

Partager
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Circulating Tumor Dna Market Infographic
Purchase Options

Circulating Tumor Dna Market Résumé

Les principales entreprises du marché Circulating Tumor Dna Market incluent

Portée du rapport

Laisser un commentaire

FAQs

What is the projected market valuation of the Circulating Tumor DNA (ctDNA) Market by 2035?

The Circulating Tumor DNA (ctDNA) Market is projected to reach a valuation of 31.28 USD Billion by 2035.

What was the market valuation of the ctDNA Market in 2024?

In 2024, the overall market valuation of the Circulating Tumor DNA (ctDNA) Market was 6.866 USD Billion.

What is the expected CAGR for the ctDNA Market during the forecast period 2025 - 2035?

The expected CAGR for the Circulating Tumor DNA (ctDNA) Market during the forecast period 2025 - 2035 is 14.78%.

Which application segment is projected to have the highest valuation by 2035?

The Therapeutic Monitoring application segment is projected to reach 9.0 USD Billion by 2035.

What are the key technologies driving the ctDNA Market growth?

Key technologies driving growth include Next Generation Sequencing, projected to reach 11.5 USD Billion by 2035.

Which end-use segment is expected to dominate the ctDNA Market by 2035?

The Hospitals end-use segment is expected to dominate, with a projected valuation of 12.36 USD Billion by 2035.

What product types are included in the ctDNA Market, and which is expected to grow the most?

Reagents and Kits are included, both projected to reach 9.25 USD Billion by 2035, indicating strong growth.

Who are the key players in the Circulating Tumor DNA (ctDNA) Market?

Key players include Illumina, Guardant Health, Roche, and Natera, among others.

Télécharger l'échantillon gratuit

Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions